Perinatal Outcomes in Siblings from Different Conception Methods: In Vitro Fertilization with Autologous Oocyte or Donor Egg vs. Unassisted Medical Conception

To study the perinatal outcomes of children born from different conception methods: in vitro fertilization (IVF) with autologous oocytes or IVF with donor egg versus those conceived without

A blastocyst’s implantation potential is linked to its originating oocyte cohort’s blastulation rate: evidence for a cohort effect

To investigate if blastocysts originating from different follicular cohorts have variable implantation rates, adjusted for oocyte age, morphology and/or ploidy

Low doses of alkylating agents do not harm human ovarian tissue destined for cryopreservation

To investigate the impact of non-gonadotoxic doses of alkylating agents on human ovarian cortex.

To Be Frank: Is it Time to Say Goodbye to Abbe-McIndoe and Vecchietti?

Preeclampsia: more than just a maternal disease

The concept of a “dangerous father” is not new in the context of the risk of maternal preeclampsia in relation to the identity of the male partner. Previous studies have suggested that the

Polycystic ovarian morphology: the number of chocolate chips is more important than the size of the cookie

Polycystic ovary syndrome (PCOS) may very well be the most misdiagnosed condition in the field of women’s health. In my clinical practice, almost no week goes by without a patient who has blatant

Prediction of menstrual cycle phase using cross-sectional measurements of reproductive hormones

Health and disease activity can vary by menstrual cycle phase (1, 2). Reliable assessment of cycle phase is, therefore, critical to the management and study of gynecologic and nongynecologic

Exploring new frontiers in the management of polycystic ovary syndrome associated obesity

For the past 5 years, several landmarks worldwide are lit up in teal each September to celebrate polycystic ovary syndrome (PCOS) awareness month. With each passing year, we recognize the

Donor incentives revisited

This issue’s Fertile Battle revisits a conundrum that has existed since the advent of gamete donation. How do we balance the needs of potential recipients against a limited resource and the

Antimüllerian hormone and antral follicle count thresholds for hyperresponse risk assessment in in vitro fertilization: a Hyperresponse Risk Assessment consensus study

To determine the serum antimüllerian hormone (AMH) and antral follicle count (AFC) thresholds indicating an increased risk of hyperresponse to ovarian stimulation (OS) during in vitro